Labetalol against Alpha Methyldopa for the treatment gestational hypertention

Background: The most frequent medical condition is hypertension. It is associated by a higher chance of adverse effects all throughout pregnancy. aim of study: to match alpha methyldopa and labetalol's effectiveness in decreasing blood pressure in expectant mothers with hypertension caused by pregnancy (PIH). results: Significant differences were found between the study groups referring to the typical drop in and Diastolic and Systolic blood pressure, and Comparing to the -Methyldopa group, the labetalol group required considerably less time to control blood pressure. conclusion: A significant issue is high Bp during pregnancy. The root of all illnesses and fatalities globally. Drugs that treat hypertension play a significant role in the management of BP in mothers. In this research, we discovered that labetalol regulates diastolic and systolic function more rapidly and effectively than methyldopa. This conclusion is consistent with other observations that labetalol is efficient and ensures faster drug being used in achieving satisfactory Bp control in PIH.